The reason for the different patterns of CTLA-4 molecule expression in response to ex vivo DSP30+rIL-2 stimulation in the studied groups of CLL patients requires further clarification. The gene discussed is CTLA4; the disease is B-cell chronic lymphocytic leukemia.